行情

CDXS

CDXS

Codexis
NASDAQ

实时行情|Nasdaq Last Sale

18.11
-0.46
-2.48%
盘后: 18.11 0 0.00% 16:41 01/17 EST
开盘
18.61
昨收
18.57
最高
18.69
最低
17.99
成交量
33.81万
成交额
--
52周最高
22.49
52周最低
12.68
市值
10.60亿
市盈率(TTM)
-83.7650
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CDXS 新闻

  • Codexis Attends Opening Ceremony for Portons Fermentation Pilot Lab in Chongqing
  • GlobeNewswire.5天前
  • Codexis and Nestlé Health Science Sign Development Agreement to Advance Therapeutic Candidate towards Clinical Studies and Extend Strategic Collaboration Agreement
  • GlobeNewswire.01/10 12:00
  • We're Not Very Worried About Codexis's (NASDAQ:CDXS) Cash Burn Rate
  • Simply Wall St..01/01 14:06
  • The Daily Biotech Pulse: NewLink Genetics Licenses Ovarian Cancer Dug, Correvio Awaits FDA Verdict
  • Benzinga.2019/12/24 12:24

更多

所属板块

生物技术和医学研究
-0.16%
制药与医学研究
+0.06%

热门股票

名称
价格
涨跌幅

CDXS 简况

Codexis, Inc. is a protein engineering company. The Company is engaged in the development of biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals. The Company operates through its two segments, such as the performance enzymes and novel biotherapeutics. It provides enzyme optimization services from small scale through to commercial quantities and also develops biocatalyst products. It is also engaged in the development of manufacturing processes for active pharmaceutical ingredients, fine chemicals and food ingredients. Its CodeEvolver is a protein engineering technology platform and products in the pharmaceuticals market. The Company serves various industries, including food and food ingredients, animal feed, flavors, fragrances, and agricultural chemical.
展开

Webull提供Codexis, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。